Flaxseed and Cardiovascular Risk Factors: Results from a Double Blind, Randomized, Controlled Clinical Trial

Journal of the American College of Nutrition

Volumn 27, Issue 1, 2008, Pages 65-74

  Bloedon, LeAnne T ^a,b   Balikai, Shilpa ^a   Szapary, Philippe O ^a,b,c   Rader, Daniel J ^b   Chittams, Jesse ^c   Berlin, Jesse A ^c   Cunnane, Stephen C ^d  

^a Division of General Internal Medicine   (United States)

^b Institute of Translational Medicine and Therapeutics   (United States)

^c Leonard Davis Institute of Health Economics   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Flaxseed; Hypercholesterolemia; Inflammation; Insulin resistance; Lipoproteins; Oxidative stress

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; ISOPROSTANE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINSEED; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; WHEAT BRAN;

AGED; ALPHA-LINOLENIC ACID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DOUBLE-BLIND METHOD; FEMALE; FLAX; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; TIME FACTORS; TREATMENT OUTCOME;

TRITICUM AESTIVUM;

EID: 42649086808     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2008.10719676     Document Type: Article

References (33)

1. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65: 1645S-1654S, 1997.
2. Berry EM, Hirsch J: Does dietary linolenic acid influence blood pressure? Am J Clin Nutr 44: 336-340, 1986.
3. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willett WC: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69: 890-897, 1999.
4. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB: Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111: 157-164, 2005.
5. Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB, Jr, Mayer-Davis EJ: Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 78: 965-971, 2003.
6. Brown L, Rosner B, Willett WW, Sacks FM: Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69: 30-42, 1999.
7. Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G. Knekt P, Pietinen P. Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A: Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164: 370-376, 2004.
8. Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H, Salonen JT: Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 160: 465-469, 2002.
9. Vanharanta M, Voutilainen S, Lakka TA, van der LM, Adlercreutz H, Salonen JT: Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354: 2112-2115, 1999.
10. Bierenbaum ML, Reichstein R, Watkins TR: Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr 12: 501-504, 1993.
11. Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen ZY, Wolever TM, Kemloms DJ: High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 69: 443-453, 1993.
12. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins D: Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61: 62-68, 1995.
13. Arjmandi BH, Khan DA, Juma S, Drum ML, Venkatesh S, Sohn E: Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res 18: 1203-1214, 1998.
14. Mandasescu S, Mocanu V, Dascalita AM, Haliga R, Nestian I, Stitt PA, Luca V: Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat last 109: 502-506, 2005.
15. Clark WF, Kortas C, Heidenheim AP, Garland J, Spanner E, Parbtani A: Flaxseed in lupus nephritis: a two-year nonplacebocontrolled crossover study. J Am Coll Nutr 20: 143-148, 2001.
16. Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, Sroecker BJ, Arjmandi BH: Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87: 1527-1532, 2002.
17. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC: Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100: 495-504, 2002.
18. Stuglin C, Prasad K: Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther 10: 23-27, 2005.
19. Dodin S, Lemay A, Jacques H, Legare F, Forest J-C, Masse B: The effects of flaxseed dietary supplement on lipid profile, bone mineral density and symptoms in menopausal women: a randomized double-blind wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 90: 1390-1397, 2005.
20. Kris-Etherton P, Eissenstat B, Jaax S, Srinath U, Scott L, Rader J, Pearson T: Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. J Am Diet Assoc 101: 81-86, 2001.
21. Bazinet RP, Douglas H, Cunnane SC: Whole-body utilization of n-3 PUFA in n-6 PUFA-deficient rats. Lipids 38: 187-189, 2003.
22. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410, 2000.
23. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J, Perez-Jimenez F: Influence of mutation in human apolipoprotein A-1 gene promoter on plasmaLDL cholesterol response to dietary fat. Lancet 343: 1246-1249, 1994.
24. Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC: Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr 69: 395-402, 1999.
25. Kostner KM, Kostner GM: Factors affecting plasma lipoprotein(a) levels: role of hormones and other nongenetic factors. Semin Vasc Med 4: 211-214, 2004.
26. Wilkinson P, Leach C, Ah-Sing EE, Hussain N, Miller GJ, Millward DJ, Griffin BA: Influence of [alpha]-linolenic acid and fishoil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 181: 15-124, 2005.
27. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM: Dietary (alpha)-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134: 2991-2997, 2004.
28. Bhathena SJ, Ali AA, Haudenschild C, Latham P, Ranich T, Mohamed AI, Hansen CT, Velasquez MT: Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity. J Am Coll Nutr 22: 157-164, 2003.
29. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and creactive protein in the west of Scotland coronary prevention study. Diabetes 53: 2855-2860, 2004.
30. Bemelmans WJ, Lefrandt JD, Feskens EJ, van Haelst PL, Broer J, Meyboom-de Jong B, May JF, Tervaert JW, Smit AJ: Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 58: 1083-1089, 2004.
31. Esposito K, Marfella R, Ciotola M, Di PC, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292: 1440-1446, 2004.
32. McGrath LT, Brennan GM, Donnelly JP, Johnston GD, Hayes JR, McVeigh GE: Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus. Atherosclerosis 121: 275-283, 1996.
33. Mori TA, Puddey IB, Burke V, Croft KD, Dunstan DW, Rivera JH, Beilin LJ: Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep 5: 45-46, 2000.